Avandia and Byetta are two drugs used for treatment of Type 2 diabetes, and both drugs have recently been associated with two very different, yet serious side effects. Concerns have emerged among diabetics and their doctors about potential heart side effects of Avandia and about potential… Read More
The diabetes drug Avandia has been associated with a 40% increase in the risk of heart attacks, as well as an increased risk of congestive heart failure, bone fractures and in some cases vision loss. A recent editorial in a medical journal questions the FDA's decision… Read More
An FDA advisory panel recommended yesterday that diabetes drugs should be subjected to tougher standards before being approved, to protect patients from heart risks. The advisory opinion was sought by the FDA after they were subjected to intense criticism for not discovering Avandia risks that could… Read More
Two new studies in the Archives of Internal Medicine provide new evidence about side effects of Avandia, Actos and Fosamax. One study established a heightened risk of bone fractures among Avandia and Actos users. The other study found a connection between women who used the osteoporosis… Read More
Despite the fact that the FDA narrowly voted in October 2007 to not issue an Avandia recall, many doctors have taken the matter into their own hands and stopped prescribing the dangerous diabetes drug. Amid concerns that Avandia increases the risk of heart attacks and other… Read More
GlaxoSmithKline Plc, maker of the diabetes drug Avandia, received a harsh warning letter from the FDA this week as a result of their failure to report safety results as required by federal regulations. Over the past year, a lot of attention has been focused on Avandia… Read More
This week, the FDA and GlaxoSmithKline released a new Medication Guide for Avandia (rosiglitazone maleate), which will be provided with each prescription dispensed. The Guide includes detailed information about the side effects of Avandia, including a potential increased risk of heart attacks, congestive heart failure and… Read More
Although it violated the confidentiality rules of the New England Journal of Medicine, GlaxoSmithKline was provided an advance copy of an article published in May 2007 which linked Avandia to an increased risk of heart attacks. The study was leaked during the peer review process by… Read More
According to estimates made by FDA staff scientists, approximately 83,000 additional heart attacks have been caused by Avandia since the drug came onto the market. Information outlined in a Senate Finance Committee report suggests that many of these Avandia heart attacks could have been avoided if… Read More
Since May 2007, the lawyers at Saiontz & Kirk, P.A. have been representing users of Avandia who are pursuing lawsuits as a result of heart attacks and other heart related problems caused by the diabetes drug. Following a study released last month, Avandia fracture lawsuits are… Read More
